NIH-Funded Study to Increase HPV Vaccination Rates: One Year Later
February 23, 2018
In December 2016, Debra Friedman, M.D., the E. Bronson Ingram Chair in Pediatric Oncology, and Pamela Hull, Ph.D., assistant professor of medicine in the Division of Epidemiology, began an implementation study, funded by a NIH R01 grant, to focus on increasing HPV vaccination rates among adolescents. The five-year study is a collaboration with Cumberland Pediatric Foundation.
The HPV vaccine represents an unprecedented opportunity to prevent the vast majority of HPV-related cancers. However, nationally, the 43-percent HPV vaccine completion rate continues to lag behind that of other adolescent vaccines (over 80 percent). This rate is even lower in Tennessee (36 percent), where the burden of HPV-related cancers, including cervical and oropharyngeal cancers, is one of the highest in the nation.
The goal of the study is to work with CPF community-based pediatric practices in Middle Tennessee to compare the clinical and cost effectiveness of web-based versus in-person coaching to deliver quality improvement education focused on enhanced HPV vaccination in adolescent girls and boys. The Department of Pediatrics is also collaborating to provide Part IV MOC credit for participating pediatricians.
Through this study, 25 practices have begun implementing the program, with 13 participating in web-based coaching and 12 using in-person coaching. To date, 135 physicians have elected to receive MOC credit.
For more information about the study, contact Pamela Hull.